This month results of the clinical phase II (400 patients) will be published.
I read cogane has already been tested in a clinical phase II for Alzheimer's disease. This was already done back in 2005-2006. I actually don't understand why they didn't move towards a clinical phase III for AD ? Anyone knows more about this ? I have the feeling that if cogane doesn't help AD, then my hopes for it to help PD are also small.

I found more about the cogane trial for AD. Apparently both the cogane treated group and the placebo group returned better cognition. ????????? :fearful:

That's very weird !!!